Product Information
KAZANO 12.5-500 MG TABLET is a brand product labeled by Takeda Pharmaceuticals America, Inc., priced at $6.5885 per EA under NDC 64764033560. Its NADAC has been published 278 times since Feb 19, 2014.
FDA first approved this application on Jan 25, 2013.
Strength
12.5; 500 mg/1; mg/1
Manufacturer
Takeda Pharmaceuticals America, Inc.NDC
64764033560
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/18/2024
Active Ingredients
ALOGLIPTIN BENZOATE; METFORMIN HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA203414FDA Approved
1/25/2013
On Market Since
1/25/2013
Pharmacological Classes
Price Statistics
The NADAC for KAZANO 12.5-500 MG TABLET has been published 278 times since Feb 19, 2014, and over the history we have for it it has risen 44.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $6.5885 per EA |
|---|---|
| All-time high | $6.5908 (Aug 14, 2024) |
| All-time low | $4.5723 (Feb 19, 2014) |
| 52-week high | $6.5885 |
| 52-week low | $6.5885 |
| Median price | $5.8139 |
| Average price | $5.7322 |
| Largest weekly change | +9.9% (Apr 17, 2024) |
| Weeks tracked | 278 |
| Tracking since | Feb 19, 2014 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
0.0%
3Y
+10.0%
5Y
+10.0%
All
+44.1%
Last surveyed Sep 10, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 65% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of KAZANO 12.5-500 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for KAZANO 12.5-500 MG TABLET, manufactured by Takeda Pharmaceuticals America, Inc., is $6.5885 per EA (NDC 64764033560), effective Sep 10, 2025.
How has the price of KAZANO 12.5-500 MG TABLET changed over time?
Over the history we have for it, the NADAC for KAZANO 12.5-500 MG TABLET has risen 44.1%. It has been tracked across 278 weekly CMS publications since Feb 19, 2014.
What are the highest and lowest recorded NADAC prices for KAZANO 12.5-500 MG TABLET?
Since Feb 19, 2014, the NADAC for KAZANO 12.5-500 MG TABLET has ranged from a low of $4.5723 (Feb 19, 2014) to a high of $6.5908 (Aug 14, 2024), with a median of $5.8139 per EA.
Are there cheaper alternatives to KAZANO 12.5-500 MG TABLET?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ALOGLIPTIN-METFORMIN 12.5-500, is $2.3006 per EA — about 65% below KAZANO 12.5-500 MG TABLET.
Who manufactures KAZANO 12.5-500 MG TABLET?
KAZANO 12.5-500 MG TABLET (NDC 64764033560) is labeled by Takeda Pharmaceuticals America, Inc., and CMS classifies it as a brand product.